PTK2 and oral cavity cancer: In oral cavity cancer, EGRF has been reported to be involved in the mitogen-activated protein (MAPK) and focal adhesion kinase (FAK) pathways via the ER [17,18,19] Although ER and PgR expression has been demonstrated in oral cavity cancer, the role of sex hormones in tumor development remains uncertain.